Global transthyretin amyloidosis treatment market statistics, by hereditary transthyretin amyloidosis, 2018-2030 (USD Million)

Global hereditary transthyretin amyloidosis transthyretin amyloidosis treatment market outlook size was valued at 2,292.2 USD million in 2023 and is estimated to grow at a compound annual growth rate (CAGR) of 13.9% from 2024 to 2030.

Global transthyretin amyloidosis treatment market statistics, by hereditary transthyretin amyloidosis, 2018-2030 (USD Million)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Global transthyretin amyloidosis treatment market statistics, by hereditary transthyretin amyloidosis, 2018-2030 (USD Million)
Unlock Premium

Related Markets

Transthyretin Amyloidosis Treatment Market Scope

Transthyretin amyloidosis treatment market segmentation & scope
Vyndaqel/ Vyndamax
Onpattro
Amvuttra
Tegsedi
Wainua
Supportive Therapy
Pipeline Therapy
ATTR with Polyneuropathy (ATTR-PN)
ATTR with Cardiomyopathy (ATTR-CM)
Polyneuropathy
Cardiomyopathy
Mixed Type
Wild Type Amyloidosis
Hospital Pharmacies
Specialty Pharmacies
Retail Pharmacies
Online Pharmacies
report
Transthyretin Amyloidosis Treatment Market Outlook
  • PDF
  • HTML
  • PPT
  • -
Everything on Transthyretin Amyloidosis Treatment Market Outlook in one document: edited and divided into chapters, including detailed references.

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more